Ly Tu

机构：Inserm, Université Paris-Saclay, Shenzhen Bay Laboratory, Hypertension pulmonaire : physiopathologie et innovation thérapeutique, Center for Translational Molecular Medicine, Bicêtre Hospital · ORCID：0000-0003-2336-5099

发表论文 213 篇 · 总被引 6745 次 · h-index 43

代表论文

• Long-Acting and Stapled GLP-1R/GIPR/GCGR Triple Agonist for the Treatment of Obesity and Atherosclerosis (2025 · Journal of Medicinal Chemistry · 被引 9)
• Bone morphogenetic protein-9 controls pulmonary vascular growth and remodeling (2025 · Proceedings of the National Academy of Sciences · 被引 9)
• IDO‐1 Promotes Pulmonary Vascular Remodeling Via Kynurenine Pathway in Pulmonary Arterial Hypertension (2025 · Journal of the American Heart Association · 被引 8)
• Nicotine Reprograms Aging‐Related Metabolism and Protects Against Motor Decline in Mice (2025 · Advanced Science · 被引 5)
• Placental growth factor modulates endothelial NO production and exacerbates experimental hepatopulmonary syndrome (2024 · JHEP Reports · 被引 5)
• Blockade of PVN neuromedin B receptor alleviates inflammation via the RAS/ROS/NF-κB pathway in spontaneously hypertensive rats (2024 · Brain Research Bulletin · 被引 4)